Wang David H, director at ACM Research, sells $3.46m in shares

Published 05/09/2025, 21:38
Wang David H, director at ACM Research, sells $3.46m in shares

Director David H. Wang of ACM Research, Inc. (NASDAQ:ACMR), a $1.76 billion market cap company, sold a total of 70,000 shares of Class A Common Stock on September 3rd and 4th, 2025, for approximately $3.46 million. The sales were executed at prices ranging from $26.44 to $27.31, near the current trading price of $27.41. According to InvestingPro analysis, ACMR is currently trading at an attractive valuation relative to its growth prospects.

The transactions, were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 29, 2024.

On September 3, Wang sold 66,057 shares at a weighted average price of $26.73 and 3,943 shares at a weighted average price of $27.31. On September 4, Wang sold 60,000 shares at a weighted average price of $26.44.

Separately, on September 3 and 4, Wang exercised options to acquire 70,000 and 60,000 shares respectively, at a price of $1 per share, for a total value of $130,000. The company maintains a strong financial position, with analyst price targets ranging from $30 to $40.10, suggesting potential upside from current levels.

In other recent news, ACM Research Inc . announced its second-quarter 2025 earnings, showcasing a mixed financial outcome. The company reported an earnings per share (EPS) of $0.54, which exceeded analyst expectations of $0.4816 by 12.13%. However, the revenue figures did not meet forecasts, as the company generated $215.4 million compared to the anticipated $224.3 million. Despite the earnings per share surpassing predictions, the revenue shortfall was notable. These recent developments highlight a challenging period for ACM Research, as revenue performance plays a crucial role for investors. The earnings announcement has drawn attention from various analyst firms, offering differing perspectives on the company’s financial health. While upgrades or downgrades were not specified, the mixed results may influence future analyst recommendations. Investors continue to monitor ACM Research’s financial updates closely.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.